Leelyn Smith’s Amphenol APH Stock Holding History

Leelyn Smith’s Portfolio APH Stock Details APH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33M	Buy	37,788 +3,436	+10%	+$248K	0.41%	69
2026 Q1	$2.17M	Buy	34,352 +4,566	+15%	+$321K	0.3%	82
2025 Q4	$2.01M	Buy	+29,786	New	+$1.99M	0.29%	86
2020 Q1	–	Sell	-10,200	Closed	-$16K	–	322
2019 Q4	$16K	Buy	+10,200	New	+$130K	0.01%	237

Other funds holding APH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Leelyn Smith's APH Position: Q2 2026 in Review

Leelyn Smith increased its Amphenol (APH) stake by 10% in Q2 2026, buying an estimated $248K and bringing the position to 37,788 shares worth $3.33M. The position accounts for 0.41% of the portfolio, ranked #69.

Leelyn Smith first reported a position in APH in Q4 2019 and has held it in 4 quarters since. 2,340 funds tracked by Wall St. Rank hold APH as of Q2 2026.

Leelyn Smith held 37,788 shares of Amphenol worth $3.33M as of Q2 2026.
Leelyn Smith bought 3,436 Amphenol shares in Q2 2026, an estimated $248K.
Amphenol made up 0.41% of Leelyn Smith's portfolio in Q2 2026, its #69 holding.
Leelyn Smith first reported a position in Amphenol in Q4 2019 and has held it in 4 quarters since.
2,340 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.